The combination therapy with venetoclax in therapeutic strategy of acute lymphoblastic leukemia
Abstract Background Acute lymphoblastic leukemia (ALL) is characterized by the malignant transformation and proliferation of lymphoid progenitor cells in the bone marrow, blood, and extramedullary sites. Leukemic cells can develop drug resistance both before and after treatment, complicating disease...
שמור ב:
| Principais autores: | , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Springer
2026-03-01
|
| סדרה: | Discover Oncology |
| נושאים: | |
| גישה מקוונת: | https://doi.org/10.1007/s12672-026-04593-1 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|